Naveen Krishnan

Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning.

Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA.

TOMA Biosciences, Inc. develops and provides DNA-based cancer testing technology. The company was founded by Hanlee Ji, Lincoln Nadauld, James M. Ford, and Calvin J. Kuo in 2011 and is headquartered in Foster City, CA.

Trident Labs, Inc. engages in the operation of toxicology laboratories. It offers urine and oral fluid drug testing to help medical offices monitor adherence to prescription medication and abstinence from illicit drugs. The company is headquartered in Holland, MI.

The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California.

Khloris Biosciences, Inc. operates as biotechnology company. The firm offers drug discovery, vaccine and cell therapies for treatment and prevention of cancer. The company was founded by Lynne A. Bui and Joseph C. Wu in June 2017 and is headquartered in Mountain View, CA.

eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA.

Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA.

By Design (UK) Ltd. sells interior decorations, fixtures, and home furniture online. It also provides advises on home decorations. The company was founded by Martha Lane Fox, Brent Shawzin Hoberman, Paul Chudleigh and David Kelly in 2006 and is headquartered in Brighton, the United Kingdom.

Daum GmbH & Co. KG is a German company that specializes in textile finishing services such as embroidery, laser branding, and transfer printing. The private company was founded in 2002 and is based in Trautskirchen, Germany. The company offers full-service solutions and fast project processing with a focus on high-quality results.

Tafkak, Inc. provides genome sequencing and analysis solutions. It offers tools and solutions to researchers, drug developers and clinicians determine the genetic basis of human disease and drug response. The firm provides knomeCLINIC a software suite that helps medical researchers and clinicians interpret human genomes for biological relevance; kGAP a cloud-enabled genome informatics engine that automates the process of standardizing, distilling, annotating and comparing sequence data. It also offers knomeVARIANTS, a discovery-supportive interpretation tool, which helps researchers to find causal variants and genes. The company was founded by Jorge Conde and George M. Church in 2007 and is headquartered in Waltham, MA.

Part of Avancen MOD Corp., Avancen, Inc. manufactures industrial rubber goods, rubberized fabrics, and miscellaneous rubber specialties. The company is based in Palm Coast, FL.

Walden Catalyst Management LLC (Walden Catalyst) is a venture capital subsidiary of Walden International LLC founded in 2020 by Young K. Sohno. The firm is headquartered in San Francisco, California.

aiMotive Informatikai Kft. engages in the provision of automated driving solutions. Its products and services include research and development, self-driving software, proprietary simulation tools, neural network acceleration hardware, artificial intelligence, and advanced driver assistance systems. The company was founded by László Norbert Kishonti on June 12, 2015 and is headquartered in Budapest, Hungary.

Graphcore Ltd. develops a processor and modules for machine learning. The company was founded by Simon Knowles and Nigel Jurgen Toon in 2016 and is headquartered in Bristol, the United Kingdom.

Odoo SA provides business application software. It offers suite of business applications covering all business needs, from Website/E-commerce down to manufacturing, inventory and accounting, all seamlessly integrated. The company was founded by Fabien Pinckaers in 2004 and is headquartered in Grand-Rosiere, Belgium.

Boston Heart Diagnostics Corp. provides cardiovascular disease clinical services. It specializes in diagnostic testing, personalized treatment recommendations and personalized wellness programs. The company was founded by Bela F. Asztalos and Ernst J. Schaefer in 2007 and is headquartered in Framingham, MA.

Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco.

Trotana, Inc. discovers and develops medicines. The company is based in San Diego, CA. The CEO of the company is Hamza Suria.

Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC.

FerruMax Pharmaceuticals, Inc. engages in the business of pharmaceutical preparations. The private company is based in Sherbon, MA.

Abide Therapeutics, Inc. develops medicines that target serine hydrolases. Its approach is to selectively block serine hydrolases, potentially expanding this class of commercially validated enzymes as targets in a range of indications. The firm has a technology platform that exploits a chemoproteomics approach to selectively target serine hydrolases and rapidly identify target lead pairs. The company was founded by Alan B. Ezekowitz, Dale Boger, John Kennedy Clarke, Benjamin F. Cravatt, Todd Jones, Keith F. Lenden, and Paul R. Schimmel in 2011 and is headquartered in San Diego, CA.

Southern Methodist University is a private university near the center of Dallas, SMU offers undergraduate, graduate, and professional programs through seven schools in the humanities and sciences, business, the performing, visual, and communication arts, engineering, education and human development, law, and theology.

Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation

Vividion Therapeutics, Inc. operates as a biotechnology company. The company focuses on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome wide drug and target discovery. It's proprietary chemoproteomic platform technology addresses the key limitations of conventional screening techniques and allows the discovery of previously unknown, or cryptic, functional pockets on the surface of proteins and identification of small molecules that selectively bind to those targets. The company was founded by Benjamin F. Cravatt, Phil S. Baran, Jin-Quan Yu and John K. Clarke on December 24, 2013 and is headquartered in San Diego, CA.